Processa Pharmaceuticals logo
Processa Pharmaceuticals PCSA
$ 1.37 5.38%

Quarterly report 2024-Q2
added 08-13-2024

report update icon

Processa Pharmaceuticals EV/EBITDA Ratio 2011-2024 | PCSA

Annual EV/EBITDA Ratio Processa Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-2.51 -3.55 -14.6 -30.3 -74 -45.9 -7.71 -8.04 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-2.51 -74 -23.3